Transcutaneous Immunization Using Colonization Factor and Heat-Labile Enterotoxin Induces Correlates of Protective Immunity for EnterotoxigenicEscherichia coli
Open Access
- 1 March 2002
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 70 (3) , 1056-1068
- https://doi.org/10.1128/iai.70.3.1056-1068.2002
Abstract
EnterotoxigenicEscherichia coli(ETEC) diarrheal disease is a worldwide problem that may be addressed by transcutaneous delivery of a vaccine. In several human settings, protective immunity has been associated with immune responses toE. colicolonization factors and to the heat-labile toxin that induces the diarrhea. In this set of animal studies, transcutaneous immunization (TCI) using recombinant colonization factor CS6 and cholera toxin (CT) or heat-labile enterotoxin (LT) as the adjuvant induced immunoglobulin G (IgG) and IgA anti-CS6 responses in sera and stools and antibody responses that recognized CS6 antigen in its native configuration. The antitoxin immunity induced by TCI was also shown to protect against enteric toxin challenge. Although immunization with LT via the skin induced mucosal secretory IgA responses to LT, protection could also be achieved by intravenous injection of the immune sera. Finally, a malaria vaccine antigen, merzoite surface protein 142administered with CT as the adjuvant, induced both merzoite surface protein antibodies and T-cell responses while conferring protective antitoxin immunity, suggesting that both antiparasitic activity and antidiarrheal activity can be obtained with a single vaccine formulation. Overall, our results demonstrate that relevant colonization factor and antitoxin immunity can be induced by TCI and suggest that an ETEC traveler's diarrhea vaccine could be delivered by using a patch.Keywords
This publication has 78 references indexed in Scilit:
- Safety and Immunogenicity of Two Different Lots of the Oral, Killed Enterotoxigenic Escherichia coli -Cholera Toxin B Subunit Vaccine in Israeli Young AdultsInfection and Immunity, 2000
- Lack of Prophylactic Efficacy of an Enteric‐Coated Bovine Hyperimmune Milk Product against EnterotoxigenicEscherichia coliChallenge Administered during a Standard MealThe Journal of Infectious Diseases, 1999
- The CS6 colonization factor of human enterotoxigenic Escherichia coli contains two heterologous major subunitsFEMS Microbiology Letters, 1997
- Effect of DETOX as an adjuvant for melanoma vaccineVaccine, 1995
- Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvantVaccine, 1993
- Non-replicating oral whole cell vaccine protective against enterotoxigenicEscherichia coli(ETEC) diarrhea: Stimulation of anti-CFA (CFA/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypesFEMS Microbiology Letters, 1988
- Cross-Protection by B Subunit-Whole Cell Cholera Vaccine Against Diarrhea Associated with Heat-Labile Toxin-Producing Enterotoxigenic Escherichia coli: Results of a Large-Scale Field TrialThe Journal of Infectious Diseases, 1988
- Vaccine AdjuvantsClinical Infectious Diseases, 1980
- Protection against Experimental Cholera by AntitoxinThe Journal of Infectious Diseases, 1972
- Antitoxic Immunity in Experimental Cholera: Comparison of Immunity Induced Perorally and Parenterally in MiceThe Journal of Infectious Diseases, 1972